GlassScriptPhysician profile
Kris Gaston
NPI 1881657252
$31,759.65
in general payments reported to CMS, 2019-2025
31 companies · $28K in 2025
The $28K reported for 2025 was more than what 97% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $229 · 2021: $507 · 2022: $849 · 2023: $1,041 · 2024: $1,024 · 2025: $28K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $23K · Food and Beverage: $3,477 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,000 · Travel and Lodging: $1,580.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $23,118.70 |
| Food and Beverage | $3,476.66 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,000.00 |
| Travel and Lodging | $1,579.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Scientific Affairs, LLC | $12,266.93 | 2025 | |
| Janssen Biotech, INC. | $11,114.86 | 2025 | Erleada, Balversa |
| Avyxa Pharma, LLC | $3,846.75 | 2025 | |
| Ethicon US, LLC | $832.86 | 2019-2025 | Enseal X1, Echelon Flex, Evarrest |
| Urogen Pharma, INC. | $481.80 | 2024-2025 | |
| Dendreon Pharmaceuticals LLC | $451.43 | 2022-2025 | Provenge |
| Biom'Up France Sas | $360.10 | 2021 | |
| Intuitive Surgical, INC. | $200.53 | 2019 | |
| Medtronic, INC. | $195.11 | 2023-2024 | Interstim |
| Dilon Technologies, INC. | $179.37 | 2023 | Hemoblast Bellows |
| Novartis Pharmaceuticals Corporation | $160.62 | 2023 | |
| Immunitybio, INC. | $150.12 | 2024 | |
| Angiodynamics, INC. | $143.08 | 2023 | Nanoknife |
| Kerecis Limited | $136.30 | 2022-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Bayer Healthcare Pharmaceuticals INC. | $131.25 | 2025 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $128.57 | 2023 | Xtandi |
| Foundation Medicine, INC. | $126.86 | 2022-2023 | |
| Astrazeneca Pharmaceuticals LP | $106.54 | 2022 | |
| Astellas Pharma Global Development | $103.75 | 2024 | Xtandi |
| Blue Earth Diagnostics | $100.00 | 2024 | |
| Pfizer INC. | $96.34 | 2023-2024 | |
| Emd Serono, INC. | $94.90 | 2023 | Bavencio |
| Boston Scientific Corporation | $84.96 | 2022 | |
| Bioprotect Medical, INC. | $66.63 | 2025 | Bioprotect Balloon Implant System |
| Olympus America INC. | $50.62 | 2024 | Itind System |
| Convatec INC. | $38.19 | 2022 | |
| Coloplast Corp | $30.82 | 2023-2024 | Titan |
| Ferring Pharmaceuticals INC. | $26.26 | 2025 | Adstiladrin |
| Innovation Technologies INC | $24.66 | 2024 | Irrisept |
| 180 Medical, INC. | $15.93 | 2023 | Gentlecath Glide |
| Davol INC. | $13.51 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kris Gaston listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.